Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. (NASDAQ:ORKA) is one of the best performing healthcare stocks so far in 2026. Leerink Partners lifted the price target on Oruka Therapeutics, Inc.
Oruka Therapeutics Inc. (ORKA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 2,666,690 | $130,801,145 | 0.37% | |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 2,320,316 | $113,811,500 | +36% | 2.33% |
| 3. | Deep Track Capital David Kroin | 2,034,203 | $99,777,657 | -6% | 1.63% |
| 4. | Remedium Capital Partners David Hawkins | 1,565,661 | $76,795,672 | +1% | 27.31% |
| 5. | Perceptive Advisors Joseph Edelman | 1,395,501 | $68,449,324 | -6% | 1.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.44 | 88,794 | $1,015,803.36 | 4,148,428 | 2025-02-14 | Filing | |
| $11.63 | 14,950 | $173,868.50 | 4,059,634 | 2025-02-13 | Filing | |
| $11.86 | 8,971 | $106,396.06 | 4,044,684 | 2025-02-12 | Filing | |
| $10.95 | 9,593 | $105,043.35 | 4,035,713 | 2025-02-11 | Filing | |
| $10.90 | 574 | $6,256.60 | 4,026,120 | 2025-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.97 | 13,235 | $793,661.92 | 73,743 | 2026-05-21 | Filing | |
| $59.10 | 53,447 | $3,158,910.11 | 86,978 | 2026-05-21 | Filing | |
| $58.43 | 38,318 | $2,238,794.29 | 140,425 | 2026-05-21 | Filing | |
| $61.16 | 700 | $42,812.42 | 16,406 | 2026-05-18 | Filing | |
| $60.34 | 800 | $48,269.12 | 17,106 | 2026-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,431,403 | $364,510,318 | 0.02% | |
| 2. | 4,148,428 | $203,480,393 | 7.6% | |
| 3. | 3,705,262 | $181,743,101 | 13.13% | |
| 4. | 3,527,087 | $173,003,617 | 0% | |
| 5. | 2,058,148 | $100,952,159 | 1% |
News See All
10 Best Performing Healthcare Stocks So Far in 2026
She was of the view that the backdrop at present is featuring geopolitical tensions, Fed policy uncertainty, inflation concerns, and still, it is incredible that the stock market is at record highs.
10 Small-Cap Stocks That Are On Fire Right Now
On April 22, Bipan Rai, Head of ETF strategy at BMO Global Asset Management, joined BNN Bloomberg to discuss the transition of the global economy into a stagflation-like regime in Q2 2026.
10 Stocks Racking Up Monster Gains
In a market note, Morgan Stanley upgraded its price target for TeraWulf Inc.
H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial
Kapoor noted the early start of dosing for OKRA-002 to be a significant milestone for the company.
Hedge Fund Resource Center